Research Area
New Study Identifies Promising Inhibitor Combination for Hard-to-Treat Leukemia Subtypes
Faculty In This Story Assistant Professor of Biomedical Sciences M. Andrés Blanco, PhD, from the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet) and investigators from the Universities of…
Penn Vet and Penn Medicine Researchers Receive Nearly $6 Million in Renewed NIH Funding to Study Epigenetics of Reproduction in Animals and Humans
A multidisciplinary group of researchers from the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet) and the University’s Perelman School of Medicine (Perelman) have received $5.95 million in renewed…
Removing the barrier surrounding solid tumors clears path for T cells (link is external)
Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T cells to infiltrate and attack the tumor…
Genetic switch turns tumor suppressor into oncogene in colorectal cancer (link is external)
Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.
Blocking tumor signals can hinder cancer’s spread (link is external)
For most people who die of cancer, the spread of the initial tumor is to blame. “Metastasis is what kills most cancer patients,” says Serge Fuchs, a professor in Penn’s School of…